Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1332 to 1381 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1332\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
my016 protein. [source:sptrembl;acc:q9h3k6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4775.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5158.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08033\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1333\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
abl-interactor 2; abl-interacting protein 1 (sh3-containing protein); abl binding protein 3; arg protein tyrosine kinase-binding protein; abl-interactor protein 2b; similar to spectrin sh3 domain binding protein 1. [source:refseq;acc:nm\_005759]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5803.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6269.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0802\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1334\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
spectrin sh3 domain binding protein 1; eps8 binding protein; interactor protein ablbp4; abl-interactor protein 1 long; nap1 binding protein. [source:refseq;acc:nm\_005470]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5804.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6270.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08018\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1335\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
coatomer beta subunit (beta-coat protein) (beta-cop). [source:swissprot;acc:p53618]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10430.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9656.4\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08014\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1336\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
g1 to s phase transition protein 1 homolog (gtp-binding protein gst1-hs). [source:swissprot;acc:p15170]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6140.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6632.24\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1337\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gtp cyclohydrolase i (ec 3.5.4.16) (gtp-ch-i). [source:swissprot;acc:p30793]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4935.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5329.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0799\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1338\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
megf6 (fragment). [source:sptrembl;acc:o75095]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5980.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6457.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07978\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1339\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
6-phosphogluconate dehydrogenase, decarboxylating (ec 1.1.1.44). [source:swissprot;acc:p52209]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5988.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6464.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07964\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1340\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit beta type 4 precursor (ec 3.4.25.1) (proteasome beta chain) (macropain beta chain) (multicatalytic endopeptidase complex beta chain) (proteasome chain 3) (hsn3) (hsbpros26). [source:swissprot;acc:p28070]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5979.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6453.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07935\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1341\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-actinin 2 (alpha actinin skeletal muscle isoform 2) (f-actin cross linking protein). [source:swissprot;acc:p35609]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5887.82\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6354.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07928\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1342\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual-specificity tyrosine-phosphorylation regulated kinase 1b (ec 2.7.1.-) (mirk protein kinase). [source:swissprot;acc:q9y463]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5887.86\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6354.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07926\vspace{3pt}}\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1343\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual-specificity tyrosine-phosphorylation regulated kinase 1a (ec 2.7.1.-) (protein kinase minibrain homolog) (mnbh) (hp86) (dual specificity yak1-related kinase). [source:swissprot;acc:q13627]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6354.5\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07925\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1344\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
elongation protein 4 homolog; pax6 neighbor gene; chromosome 11 open reading frame 19. [source:refseq;acc:nm\_019040]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1345\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-actinin 1 (alpha-actinin cytoskeletal isoform) (non-muscle alpha-actinin 1) (f-actin cross linking protein). [source:swissprot;acc:p12814]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5887.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6354.47\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1346\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-actinin 4 (non-muscle alpha-actinin 4) (f-actin cross linking protein). [source:swissprot;acc:o43707]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5887.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6354.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07924\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1347\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
presenilins associated rhomboid-like protein. [source:refseq;acc:nm\_018622]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6153.36\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6640.77\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07921\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1348\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-butyrobetaine,2-oxoglutarate dioxygenase (ec 1.14.11.1) (gamma-butyrobetaine hydroxylase) (gamma-bbh). [source:swissprot;acc:o75936]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1349\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
potential phospholipid-transporting atpase ih (ec 3.6.3.1) (atpase class i type 11a) (atpase is). [source:swissprot;acc:p98196]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1350\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tetratricopeptide repeat protein 4 (my044 protein). [source:swissprot;acc:o95801]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6783.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7320.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0791\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1351\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 6 (ec 2.7.1.-) (map kinase kinase 6) (mapkk 6) (mapk/erk kinase 6) (sapkk3). [source:swissprot;acc:p52564]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6105.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6587.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07906\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1352\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 3 (ec 2.7.1.-) (map kinase kinase 3) (mapkk 3) (mapk/erk kinase 3). [source:swissprot;acc:p46734]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6104.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6586.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07902\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1353\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin c. [source:swissprot;acc:p24863]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6200.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6690.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07896\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1354\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
actin, cytoplasmic 2 (gamma-actin). [source:swissprot;acc:p02571]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6036.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6512.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07893\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1355\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ornithine carbamoyltransferase, mitochondrial precursor (ec 2.1.3.3) (otcase) (ornithine transcarbamylase). [source:swissprot;acc:p00480]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5783.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6240.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07889\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1356\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcipressin 1 (down syndrome critical region protein 1) (myocyte- enriched calcineurin interacting protein 1) (mcip1) (adapt78). [source:swissprot;acc:p53805]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5657.71\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6103.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07881\vspace{3pt}}\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1357\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj947l8.1.6 (novel cub and sushi (scr repeat) domain protein) (fragment). [source:sptrembl;acc:q9h4w2]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6103.54\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0788\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1358\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein zic 4 (zinc finger protein of the cerebellum 4) (fragment). [source:swissprot;acc:q8n9l1]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1359\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj947l8.1.1 (novel cub and sushi (scr repeat) domain protein) (fragment). [source:sptrembl;acc:q9h4v7]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1360\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcipressin 2 (thyroid hormone-responsive protein zaki-4) (down syndrome candidate region 1-like 1) (myocyte-enriched calcineurin interacting protein 2) (mcip2). [source:swissprot;acc:q14206]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5657.72\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6103.52\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07879\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1361\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcipressin 3 (down syndrome candidate region 1-like protein 2) (myocyte-enriched calcineurin interacting protein 3) (mcip3). [source:swissprot;acc:q9uka8]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1362\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sequestosome 1; ubiquitin-binding protein p62; phosphotyrosine independent ligand for the lck sh2 domain p62. [source:refseq;acc:nm\_003900]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6322.75\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6820.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07872\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1363\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nonspecific lipid-transfer protein, mitochondrial precursor (nsl-tp) (sterol carrier protein 2) (scp-2) (sterol carrier protein x) (scp-x) (scpx). [source:swissprot;acc:p22307]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1364\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein c20orf4 (protein cgi-23) (pro0225). [source:swissprot;acc:q9y312]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5815.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6272.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07868\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1365\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma adducin (adducin-like protein 70). [source:swissprot;acc:q9uey8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5799.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6255.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07862\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1366\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
megf11 protein. [source:refseq;acc:nm\_032445]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5793.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6248.79\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07858\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1367\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
megf10 protein. [source:refseq;acc:nm\_032446]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5793.47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6248.71\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1368\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta adducin (erythrocyte adducin beta subunit). [source:swissprot;acc:p35612]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5793.29\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6248.51\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1369\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha adducin (erythrocyte adducin alpha subunit). [source:swissprot;acc:p35611]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5786.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6241.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07853\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1370\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-complex associated-testis-expressed 1-like (protein 91/23). [source:swissprot;acc:p51808]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
10231.8\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
9487.34\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07847\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1371\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
double-strand break repair protein mre11a (mre11 homolog 1). [source:swissprot;acc:p49959]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1372\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lin-7 homolog a; vertebrate lin7 homolog 1; tax interaction protein 33; mammalian lin-7 1. [source:refseq;acc:nm\_004664]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5743.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6193.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07835\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1373\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitogen-activated protein kinase 3 (ec 2.7.1.37) (extracellular signal-regulated kinase 1) (erk-1) (insulin-stimulated map2 kinase) (map kinase 1) (mapk 1) (p44-erk1) (ert2) (p44-mapk) (microtubule- associated protein-2 kinase). [source:swissprot;acc:p27361]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6079.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6556.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07833\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1374\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s6 kinase alpha 3 (ec 2.7.1.37) (s6k-alpha 3) (90 kda ribosomal protein s6 kinase 3) (p90-rsk 3) (ribosomal s6 kinase 2) (rsk-2) (pp90rsk2) (insulin-stimulated protein kinase 1) (ispk-1). [source:swissprot;acc:p51812]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6079.45\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6555.4\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07829\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1375\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcium/calmodulin-dependent protein kinase type ii gamma chain (ec 2.7.1.123) (cam-kinase ii gamma chain) (cam kinase ii gamma subunit) (camk-ii gamma subunit) (fragment). [source:swissprot;acc:q13555]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1376\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcium/calmodulin-dependent protein kinase type ii delta chain (ec 2.7.1.123) (cam-kinase ii delta chain) (cam kinase ii delta subunit) (camk-ii delta subunit). [source:swissprot;acc:q13557]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6079.46\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6555.41\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1377\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitogen-activated protein kinase kinase kinase 6 (ec 2.7.1.-). [source:swissprot;acc:o95382]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6555.4\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1378\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
signal-induced proliferation-associated 1-like 1. [source:refseq;acc:nm\_015556]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6079.45\vspace{3pt}}&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1379\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s6 kinase alpha 1 (ec 2.7.1.37) (s6k-alpha 1) (90 kda ribosomal protein s6 kinase 1) (p90-rsk 1) (ribosomal s6 kinase 1) (rsk-1) (pp90rsk1). [source:swissprot;acc:q15418]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6079.46\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6555.41\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1380\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-binding cassette, sub-family d, member 3 (70 kda peroxisomal membrane protein) (pmp70). [source:swissprot;acc:p28288]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1381\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutaryl-coa dehydrogenase, mitochondrial precursor (ec 1.3.99.7) (gcd). [source:swissprot;acc:q92947]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/